Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection: Repeat analyses with updated data for the prospective cohort study in the Netherlan... by Anne J. Huiberts, Susan van den Hof, Mirjam J. Knol

Get full text

SARS-CoV-2 risk factors among symptomatic vaccinated adults attending community testing locations in the Netherlands from June 2021 till February 2022. by Claudia Laarman, Susan J Hahné, Hester E de Melker, Mirjam J Knol

Get full text

SARS-CoV-2 risk factors among symptomatic vaccinated adults attending community testing locations in the Netherlands from June 2021 till February 2022 by Claudia Laarman, Susan J. Hahné, Hester E. de Melker, Mirjam J. Knol

Get full text

Potential misinterpretation of treatment effects due to use of odds ratios and logistic regression in randomized controlled trials. by Mirjam J Knol, Ruben G Duijnhoven, Diederick E Grobbee, Karel G M Moons, Rolf H H Groenwold

Get full text

Room for improvement in conducting and reporting non-inferiority randomized controlled trials on drugs: a systematic review. by Grace Wangge, Olaf H Klungel, Kit C B Roes, Anthonius de Boer, Arno W Hoes, Mirjam J Knol

Get full text

Evaluation of the surveillance system for invasive meningococcal disease (IMD) in the Netherlands, 2004–2016 by Diederik A. H. Brandwagt, Arie van der Ende, Wilhelmina L. M. Ruijs, Hester E. de Melker, Mirjam J. Knol

Get full text

Pathogen- and Type-Specific Changes in Invasive Bacterial Disease Epidemiology during the First Year of the COVID-19 Pandemic in The Netherlands by Anneke Steens, Mirjam J. Knol, Wieke Freudenburg-de Graaf, Hester E. de Melker, Arie van der Ende, Nina M. van Sorge

Get full text

Assessment of hybrid population immunity to SARS-CoV-2 following breakthrough infections of distinct SARS-CoV-2 variants by the detection of antibodies to nucleoprotein by Gerco den Hartog, Stijn P. Andeweg, Christina E. Hoeve, Gaby Smits, Bettie Voordouw, Dirk Eggink, Mirjam J. Knol, Robert S. van Binnendijk

Get full text

Evidence Synthesis in Harm Assessment of Medicines Using the Example of Rosiglitazone and Myocardial Infarction by Charlotte Rietbergen, Gudrun Stefansdottir, Hubert G. Leufkens, Mirjam J. Knol, Marie L. De Bruin, Marie L. De Bruin, Irene Klugkist, Irene Klugkist

Get full text

European data sources for computing burden of (potential) vaccine-preventable diseases in ageing adults by Estelle Méroc, Janeri Fröberg, Timea Almasi, Brita Askeland Winje, Alejandro Orrico-Sánchez, Anneke Steens, Scott A. McDonald, Kaatje Bollaerts, Mirjam J. Knol

Get full text

Timing of an adolescent booster after single primary meningococcal serogroup C conjugate immunization at young age; an intervention study among Dutch teenagers. by Susanne P Stoof, Fiona R M van der Klis, Debbie M van Rooijen, Mirjam J Knol, Elisabeth A M Sanders, Guy A M Berbers

Get full text

Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands by Mirjam J. Knol, Gertjan H.J. Wagenvoort, Elisabeth A.M. Sanders, Karin Elberse, Bart J. Vlaminckx, Hester E. de Melker, Arie van der Ende

Get full text

Invasive pneumococcal disease among adults with hematological and solid organ malignancies: A population-based cohort study by Hannah M. Garcia Garrido, Mirjam J. Knol, Jarom Heijmans, Nina M. van Sorge, Elisabeth A.M. Sanders, Heinz-Josef Klümpen, Martin P. Grobusch, Abraham Goorhuis

Get full text

Increased carriage of non-vaccine serotypes with low invasive disease potential four years after switching to the 10-valent pneumococcal conjugate vaccine in The Netherlands. by Marloes Vissers, Alienke J Wijmenga-Monsuur, Mirjam J Knol, Paul Badoux, Marlies A van Houten, Arie van der Ende, Elisabeth A M Sanders, Nynke Y Rots

Get full text

Higher-valency pneumococcal conjugate vaccines in older adults, taking into account indirect effects from childhood vaccination: a cost-effectiveness study for the Netherlands by Pieter T. de Boer, Cornelis H. van Werkhoven, Albert Jan van Hoek, Mirjam J. Knol, Elisabeth A. M. Sanders, Jacco Wallinga, Hester E. de Melker, Anneke Steens

Get full text

Sex-Related Differences in the Immune Response to Meningococcal Vaccinations During Adolescence by Milou Ohm, Anna G. C. Boef, Susanne P. Stoof, Mariëtte B. van Ravenhorst, Fiona R. M. van der Klis, Guy A. M. Berbers, Mirjam J. Knol

Get full text

Regulatory scientific advice on non-inferiority drug trials. by Grace Wangge, Michelle Putzeist, Mirjam J Knol, Olaf H Klungel, Christine C Gispen-De Wied, Antonius de Boer, Arno W Hoes, Hubert G Leufkens, Aukje K Mantel-Teeuwisse

Get full text

Dynamics and Determinants of Pneumococcal Antibodies Specific against 13 Vaccine Serotypes in the Pre-Vaccination Era. by Annemarijn C Prins-van Ginkel, Guy A M Berbers, Lucienne H Grundeken, Irina Tcherniaeva, Jelle I Wittenberns, Karin Elberse, Liesbeth Mollema, Hester E de Melker, Mirjam J Knol

Get full text

Changes in (risk) behavior and HPV knowledge among Dutch girls eligible for HPV vaccination: an observational cohort study by Robine Donken, Adriana Tami, Mirjam J. Knol, Karin Lubbers, Marianne A. B. van der Sande, Hans W. Nijman, Toos Daemen, Willibrord C. M. Weijmar Schultz, Hester E. de Melker

Get full text

Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands by Joske Hoes, Anna G. C. Boef, Mirjam J. Knol, Hester E. de Melker, Liesbeth Mollema, Fiona R. M. van der Klis, Nynke Y. Rots, Debbie van Baarle, Debbie van Baarle

Get full text